Event coordinated by the Hepatitis B Foundation

2018 International HBV Meeting Program

October 3 – 6, 2018

Palazzo dei Congressi, Piazza Vittorio Emanuele
Taormina (Messina), Italy


For a complete version of the 2018 program, click here


Satellite Symposium - HBV-Related Liver Cancer 

Wednesday, October 3 (1:00pm-5:00pm)

Featured speakers:

Anna Lok, M.D., FAASLD - Hepatitis B-Related Hepatocellular Carcinoma in the Era of Antivirals

Jessica Zucman-Rossi, M.D., Ph.D - Genomic Profile of HBV-Related HCC

Prof. Massimo Levrero, M.D. - Therapeutic Approaches for HBV-Related HCC

See Meeting Registration page for complete details.

General Sessions - Wednesday, October 3 - Saturday, October 6

  • Session I: Viral Entry and New Models
  • Session II: cccDNA and Transcription
  • Session III: Reverse Transcription and Morphogenesis
  • Session IV: Regulatory Proteins
  • Session V: Genotypes, Variants and Viral Pathogenesis
  • Session VI: Innate Immune Response
  • Session VII: Adaptive Immune Response
  • Session VIII: Workshop on Antivirals and New Therapeutic Approaches

 Keynote Lectures - Thursday, October 4 and Friday, October 5

  • Keynote Lecture I: Luigi Naldini, M.D., Ph.D - Ex Vivo and In Vivo Gene Therapy with Lentiviral Vectors: From Bench to Bedside, and Back
  • Keynote Lecture II: Alberto Mantovani, M.D. - The Yin Yang of Innate Immunity and Inflammation in Liver Carcinogenesis and Metastasis

Poster Sessions 

  • Poster Session I: Hepatocellular carcinoma, genotypes, variants, and viral pathogenesis
  • Poster Session II: Viral Entry, New Models, cccDNA, Transcription, Regulatory proteins, Reverse Transcription, and Morphogenesis
  • Poster Session III: Innate & Adaptive Immune Responses, and Antiviral Therapies